Potential role of microRNAs in human diseases and the exploration on design of small molecule agents

Yaoxue Xuebao

Volumn 42, Issue 11, 2007, Pages 1115-1121

  Zhang, Yong ^a   Lü, Yan Jie ^a   Yang, Bao Feng ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Arrhythmia; Drug design; Heart failure; Hypertension; MicroRNAs; Neoplasm

Indexed keywords

MESSENGER RNA; MICRORNA;

ANIMAL; DRUG DESIGN; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE SILENCING; GENE THERAPY; GENETICS; HEART DISEASE; HUMAN; HYPERTENSION; METABOLISM; METHODOLOGY; NEOPLASM; REVIEW;

ANIMALS; DRUG DESIGN; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE SILENCING; GENE THERAPY; HEART DISEASES; HUMANS; HYPERTENSION; MICRORNAS; NEOPLASMS; RNA, MESSENGER;

EID: 37549072263     PISSN: 05134870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (42)

1. Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14 [J]. Cell, 1993, 75: 843-854.
2. Van Rooij E, Sutherland LB, Liu N, et al. A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure [J]. PNAS, 2006, 103:18255-18260.
3. Lee Y, Ahn C, Han, J, et al. The nuclear RNase III Drosha initiates microRNA processing [J]. Nature, 2003, 425:415-419.
4. Lund E, Guttinger S, Calado A, et al. Nuclear export of microRNA precursors [J]. Science, 2004, 303:95-98.
5. Bstein E, Gaudy AA, Hammond S, et al. Role for abidentate ribonuclease in the initiation step of RNA interference [J]. Nature, 2001, 409:363-366.
6. Lee Y, Jeon K, Lee JT, et al. MicroRNA maturation: stepwise processing and subcellular localization [J]. EMBO J, 2002, 21:4663-4670.
7. Khvorova A, Reynolds A, Jayasena SD. Functional siRNAs and miRNAs exhibit strand bias [J]. Cell, 2003, 115:209-216.
8. Reinhart BJ, Slack FJ, Basson M, et al. The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans [J]. Nature, 2000, 403:901-906.
9. Lagos-Quintana M, Rauhut R, Yalcin A, et al. Identification of tissue-specific microRNAs from mouse [J]. Curr Biol, 2002, 12:735-739.
10. Esquela-Kerscher A, Slack FJ. Oncomirs-microRNAs with a role in cancer [J]. Nat Rev Cancer, 2006, 6: 259-269.
11. Meng F, Henson R, Lang M, et al. Involvement of human microRNAs in growth and response to chemotherapy in human cholangiocarcinoma cell lines [J]. Gastroenterology, 2006, 130:2113-2129.
12. Johnson SM, Grosshans H, Shingara J, et al. RAS is regulated by the let-7 microRNA family [J]. Cell, 2005, 120:635-647.
13. Akao Y, Nakagawa Y, Naoe T. let-7 microRNA functions as a potential growth suppressor in human colon cancer cells [J]. Biol Pharm Bull, 2006, 29:903-906.
14. Meng FY, Henson R, Wehbe-Janek H, et al. The MicroRNA let-7a modulates interleukin-6-dependent STAT-3 survival signaling in malignant human cholangiocytes [J]. J Biol Chem, 2007, 282:8256-8264.
15. Cimmino A, Calin GA, Fabbri M, et al. miR-15 and miR-16 induce apoptosis by targeting BCL2 [J]. Proc Natl Acad Sci USA, 2005, 102:13944-13949.
16. Chen JF, Mandel EM, Thomson JM, et al. The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation [J]. Nat Genet, 2006, 38:228-233.
17. Sokol NS, Ambros V. Mesodermally expressed Drosophila microRNA-1 is regulated by Twist and is required in muscles during larval growth [J]. Genes Dev, 2005, 19;2343-2354.
18. Tuddenham L, Wheeler G, Ntounia-Fousara S, et al. The cartilage specific microRNA-140 targets histone deacetylase 4 in mouse cells [J]. FEBS Lett, 2006, 580:4214-4217.
19. Zhao Y, Samal E, Srivastava D. Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis [J]. Nature, 2005, 436:214-220.
20. Naguibneva I, Ameyar-Zazoua M, Polesskaya A, et al. The microRNA miR-181 targets the homeobox protein Hox-All during mammalian myoblast differentiation [J]. Nat Cell Biol, 2006, 8:278-284.
21. Chen CZ, Li L, Lodish HF, et al. MicroRNAs modulate hematopoietic lineage differentiation [J]. Science, 2004, 303:83-86.
22. Zhao Y, Ransom JF, Li A, et al. Dysregulation of cardiogenesis, cardiac conduction, and cell cycle in mice lacking miRNA-1-2 [J]. Cell, 2007, 129:303-317.
23. Sayed D, Hong C, Chen IY, et al. MicroRNAs play an essential role in the development of cardiac hypertrophy [J]. Circ Res, 2007,100:416-424.
24. Van Rooij E, Sutherland LB, Qi XX , et al. Control of stress-dependent cardiac growth and gene expression by a microRNA [J]. Science, 2007, 316:575-579.
25. Xiao J, Yang BF, Lin HX, et al. Novel approaches for gene-specific interference via manipulating actions of microRNAs: examination on the pacemaker channel genes HCN2 and HCN4 [J]. J Cell Physiol, 2007, 212:285-292.
26. Zhang Y, Yue P, Xiao J, et al. Integration between M3 muscarinic acetylcholine receptor and connexin 43 as antiarrhythmic targets in rat ventricular myocardium [J]. Acta Pharm Sin, 2006, 41:395-400.
27. Yue P, Zhang Y, Du ZM, et al. Ischemia impairs the association between connexin 43 and M3 subtype of acetylcholine muscarinic receptor (M3-mAChR) in ventricle myocytes [J]. Cell Physiol Biochem, 2006, 17:129-136.
28. Yang BF, Lin HX, Xiao JN, et al. The muscle-specific microRNA miR-1 regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2 [J]. Nat Med, 2007, 13:486-491.
29. Anderson ME, Mohler PJ. MicroRNA may have macro effect on sudden death [J]. Nat Med, 2007, 13:410-411.
30. Kr/HERG [J]. Chin J Endemiol, 2007, 26:36-38.
31. + channel expression [J]. J Biol Chem, 2007, 282:12363-12367.
32. Ks-encoding genes and potential implications in regional heterogeneity of their expressions [J]. J Cell Physiol, 2007, 212:358-367.
33. + current [J]. Cell Physiol Biochem, 2007, 19:225-238.
34. Xu CQ, Lu YJ, Pan ZW, et al. The muscle-specific microRNAs miR-1 and miR-133 produce opposing effects on apoptosis by targeting HSP60, HSP70 and caspase-9 in cardiomyocytes [J]. J Cell Sci, 2007, 120:3045-3052.
35. Yang BF, Shan HL, Gong DM, et al. Study on the best targets of antiarrhythmic drugs [J]. J Harbin Univ Gommer (Nat Sci), 2002, 18:1-5.
36. Durand JB. Genetic basis of cardiomyopathy [J]. Curr Opin Cardiol, 1999, 14:225-229.
37. Naraba H, Iwai N. Assessment of the microRNA system in salt-sensitive hypertension [J]. Hypertens Res, 2005, 28:819-826.
38. Sethupathy P, Borel C, Gagnebin M, et al. Human microRNA-155 on chromosome 21 differentially interacts with its polymorphic target in the AGTRl 3′ untranslated region: a mechanism for functional single-nucleotide polymorphisms related to phenotypes [J]. Am J Hum Genet, 2007, 81:405-413.
39. Weiler J, HunzikerJ, Hall J. Anti-miRNA oligonucleotides (AMOs): ammunition to target miRNAs implicated in human disease [J]. Gene Ther, 2005,13:496-502.
40. Orom UA, Kauppinen S, Lund AH. LNA-modified oligonucleotides mediate specific inhibition of microRNA function [J]. Gene, 2006,372:137-141.
41. Krutzfeldt J, Rajewsky N, Braich R, et al. Silencing of microRNAs in vivo with "antagomirs" " [J]. Nature, 2005, 438:685-689.
42. Miranda KC, Huynh T, Tay Y, et al. A pattern-based method for the identification of microRNA binding sites and their corresponding heteroduplexes [J]. Cell, 2006, 126:1203-1217.